Position history for BlackRock, Inc.'s holdings in NURIX THERAPEUTICS INC
BlackRock, Inc. holds 8.9M shares of NRIX (NURIX THERAPEUTICS INC), worth $138.3M as of 2026-Q1. The position was increased (+0.6% shares). NRIX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$138.3M
Current Shares
8.9M
Total Value Change
-$6.3M
Total Shares Change
+1.2M
Other major holders of NRIX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 8.9M |
+0.6% |
| $138.3M |
| 0.0% |
| $15.81 |
30 |
| 2025-Q4 | Increased | 8.9M | +31.2% | $168.4M | 0.0% | $19.02 | 39 |
| 2025-Q3 | Decreased | 6.8M | -0.7% | $62.5M | 0.0% | $9.28 | 0 |
| 2025-Q2 | Decreased | 6.8M | -14.7% | $77.6M | 0.0% | $11.64 | 0 |
| 2025-Q1 | Increased | 8M | +4.0% | $94.9M | 0.0% | $12.15 | 31 |
| 2024-Q4 | New | 7.7M | - | $144.6M | 0.0% | $18.64 | 42 |